| Literature DB >> 33402664 |
Elisabet A Rank1, Ryan Sentosa2, Danielle J Harper2, Matthias Salas2, Anna Gaugutz2, Dana Seyringer3, Stefan Nevlacsil4, Alejandro Maese-Novo4, Moritz Eggeling4, Paul Muellner4, Rainer Hainberger4, Martin Sagmeister5, Jochen Kraft5, Rainer A Leitgeb2, Wolfgang Drexler2.
Abstract
In this work, we present a significant step toward in vivo ophthalmic optical coherence tomography and angiography on a photonic integrated chip. The diffraction gratings used in spectral-domain optical coherence tomography can be replaced by photonic integrated circuits comprising an arrayed waveguide grating. Two arrayed waveguide grating designs with 256 channels were tested, which enabled the first chip-based optical coherence tomography and angiography in vivo three-dimensional human retinal measurements. Design 1 supports a bandwidth of 22 nm, with which a sensitivity of up to 91 dB (830 µW) and an axial resolution of 10.7 µm was measured. Design 2 supports a bandwidth of 48 nm, with which a sensitivity of 90 dB (480 µW) and an axial resolution of 6.5 µm was measured. The silicon nitride-based integrated optical waveguides were fabricated with a fully CMOS-compatible process, which allows their monolithic co-integration on top of an optoelectronic silicon chip. As a benchmark for chip-based optical coherence tomography, tomograms generated by a commercially available clinical spectral-domain optical coherence tomography system were compared to those acquired with on-chip gratings. The similarities in the tomograms demonstrate the significant clinical potential for further integration of optical coherence tomography on a chip system.Entities:
Year: 2021 PMID: 33402664 PMCID: PMC7785745 DOI: 10.1038/s41377-020-00450-0
Source DB: PubMed Journal: Light Sci Appl ISSN: 2047-7538 Impact factor: 17.782